Pulmonary arterial hypertension trials in Belgium
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Leuven
- Age
- 18 years and over
- People
- 89 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-513613-12-00 · EU 2024-513613-12-00 - Phase 3Taking peopleA Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
- Where
- Leuven
- Age
- 2 years and over
- People
- 280 worldwide
- Run by
- Actelion
See details and how to joinNCT05179876 · EU 2023-506791-27-00 - Phase 2Taking peopleClinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Gent, Leuven
- Age
- 18 years to 75 years
- People
- 135 worldwide
- Run by
- NS Pharma, Inc.
See details and how to joinNCT07441200 · EU 2025-525114-38-00 - Phase 3Taking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - Phase 2Taking peopleStudy of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 99 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318597 · EU 2024-514754-79-00 - Phase 3Taking peopleA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Where
- Anderlecht, Ghent, Leuven
- Age
- 18 years to 80 years
- People
- 344 worldwide
- Run by
- Liquidia Technologies, Inc.
See details and how to joinNCT07285655 - Phase 3Taking peopleOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Anderlecht, Leuven
- Age
- 18 years to 75 years
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Anderlecht, Leuven
- Age
- 18 years to 75 years
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - No phaseEnrolling by invitationGlobal Utilization And Registry Database for Improved preservAtion of doNor LUNGs
- Where
- Leuven
- People
- 3,500 worldwide
- Run by
- Paragonix Technologies
See details and how to joinNCT04930289 - Phase 3Taking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Anderlecht, Leuven
- Age
- 18 years to 75 years
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - Phase 1/2Taking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Leuven
- Age
- 18 years to 100 years
- People
- 232 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06649110 - No phaseTaking peopleGenes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
- Where
- Leuven
- Age
- 18 years and over
- People
- 21
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT02691689 - Phase 4Taking peopleThe Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
- Where
- Aalst, Brussels, Genk, Kortrijk, Leuven, Lodelinsart, Yvoir
- Age
- 18 years and over
- People
- 306
- Run by
- Ziekenhuis Oost-Limburg
See details and how to joinNCT07359599 · EU 2025-522936-14-00 - No phaseTaking peopleCOMPERA / COMPERA-KIDS
- Where
- Leuven
- Age
- 1 week and over
- People
- 14,000 worldwide
- Run by
- Technische Universität Dresden
See details and how to joinNCT01347216 - No phaseTaking peopleCardiopulmonary Toxicity of Thoracic Radiotherapy
- Where
- Leuven
- Age
- 18 years and over
- People
- 320 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT03978377